These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27382182)

  • 21. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
    Lieberthal W; Levine JS
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of fast protein phosphorylation kinetics in single cells on a microfluidic chip.
    Blazek M; Santisteban TS; Zengerle R; Meier M
    Lab Chip; 2015 Feb; 15(3):726-34. PubMed ID: 25428717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes.
    Yasuda M; Tanaka Y; Kume S; Morita Y; Chin-Kanasaki M; Araki H; Isshiki K; Araki S; Koya D; Haneda M; Kashiwagi A; Maegawa H; Uzu T
    Biochim Biophys Acta; 2014 Jul; 1842(7):1097-108. PubMed ID: 24726883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
    Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
    PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway.
    Cuyàs E; Corominas-Faja B; Joven J; Menendez JA
    Methods Mol Biol; 2014; 1170():113-44. PubMed ID: 24906312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian target of rapamycin and tuberous sclerosis complex.
    Wataya-Kaneda M
    J Dermatol Sci; 2015 Aug; 79(2):93-100. PubMed ID: 26051878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis.
    Hoshii T; Matsuda S; Hirao A
    J Biochem; 2014 Aug; 156(2):73-83. PubMed ID: 24962700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
    Farrelly AM; Wobser H; Bonner C; Anguissola S; Rehm M; Concannon CG; Prehn JH; Byrne MM
    Diabetologia; 2009 Jan; 52(1):136-44. PubMed ID: 18949455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.
    Perl A
    Nat Rev Rheumatol; 2016 Mar; 12(3):169-82. PubMed ID: 26698023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibition of lysosomes activates the MTORC1 signaling pathway in chondrocytes in an autophagy-independent manner.
    Newton PT; Vuppalapati KK; Bouderlique T; Chagin AS
    Autophagy; 2015; 11(9):1594-607. PubMed ID: 26259639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
    Rosner M; Hengstschläger M
    Hum Mol Genet; 2008 Oct; 17(19):2934-48. PubMed ID: 18614546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ monitoring of adipogenesis with human-adipose-derived stem cells using surface-enhanced Raman spectroscopy.
    Moody B; Haslauer CM; Kirk E; Kannan A; Loboa EG; McCarty GS
    Appl Spectrosc; 2010 Nov; 64(11):1227-33. PubMed ID: 21073790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYC is an early response regulator of human adipogenesis in adipose stem cells.
    Deisenroth C; Black MB; Pendse S; Pluta L; Witherspoon SM; McMullen PD; Thomas RS
    PLoS One; 2014; 9(12):e114133. PubMed ID: 25437437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ochratoxin A inhibits adipogenesis through the extracellular signal-related kinases-peroxisome proliferator-activated receptor-γ pathway in human adipose tissue-derived mesenchymal stem cells.
    Lim S; Jang HJ; Kim JK; Kim JM; Park EH; Yang JH; Kim YH; Yea K; Ryu SH; Suh PG
    Stem Cells Dev; 2011 Mar; 20(3):415-26. PubMed ID: 20590410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin inhibits mSin1 phosphorylation independently of mTORC1 and mTORC2.
    Luo Y; Liu L; Wu Y; Singh K; Su B; Zhang N; Liu X; Shen Y; Huang S
    Oncotarget; 2015 Feb; 6(6):4286-98. PubMed ID: 25738366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight Loss Upregulates the Small GTPase DIRAS3 in Human White Adipose Progenitor Cells, Which Negatively Regulates Adipogenesis and Activates Autophagy via Akt-mTOR Inhibition.
    Ejaz A; Mitterberger MC; Lu Z; Mattesich M; Zwierzina ME; Hörl S; Kaiser A; Viertler HP; Rostek U; Meryk A; Khalid S; Pierer G; Bast RC; Zwerschke W
    EBioMedicine; 2016 Apr; 6():149-161. PubMed ID: 27211557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTORC1 regulates nutrient access in Ras-mediated tumors.
    Cheong H
    Aging (Albany NY); 2016 Jun; 8(6):1165-6. PubMed ID: 27284015
    [No Abstract]   [Full Text] [Related]  

  • 40. MTORC1 and the Rebirth of Stemness.
    Johnson NM; Lengner CJ
    Dev Cell; 2020 Oct; 55(2):113-115. PubMed ID: 33108751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.